Tag: Merrimack Pharmaceuticals

Finance

NASDAQ Losers: ON Semiconductor Corp (NASDAQ:ONNN), Endocyte (NASDAQ:ECYT), Actuate Corp (NASDAQ:BIRT), Merrimack Pharmaceuticals (NASDAQ:MACK)

ON Semiconductor Corp (NASDAQ:ONNN)’s adjusted earnings totaled $75.2 million, or 17 cents a share, while revenue increased year over year to $706.5 million from $661 million. Analysts polled by Thomson Reuters expected the company to earn 15 cents a share on revenue of $711.67 million. The company issued second-quarter revenue guidance in the range of $738 million to $768 million. ON Semiconductor Corp (NASDAQ:ONNN) stock … Continue reading NASDAQ Losers: ON Semiconductor Corp (NASDAQ:ONNN), Endocyte (NASDAQ:ECYT), Actuate Corp (NASDAQ:BIRT), Merrimack Pharmaceuticals (NASDAQ:MACK)

Colin Pettis
Finance

Healthcare Unusual Volume: Palatin Technologies (NYSEMKT:PTN), AVEO Pharmaceuticals (NASDAQ:AVEO), Aastrom Biosciences (NASDAQ:ASTM), Merrimack Pharmaceuticals (NASDAQ:MACK)

Palatin Technologies (NYSE:PTN) major shareholder Bvf Partners L. P/Il sold 540,181 shares of Palatin Technologies stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $1.14, for a total transaction of $615,806.34. Palatin Technologies, Inc. (NYSEMKT:PTN) stock performance was 17.07% in last session and finished the day at $1.44. Traded volume was 3.33 million shares in the last … Continue reading Healthcare Unusual Volume: Palatin Technologies (NYSEMKT:PTN), AVEO Pharmaceuticals (NASDAQ:AVEO), Aastrom Biosciences (NASDAQ:ASTM), Merrimack Pharmaceuticals (NASDAQ:MACK)

Jayne Crisman
BioTech

Biotech Most Volatile: CytRx Corporation (NASDAQ:CYTR), Merrimack Pharmaceuticals (NASDAQ:MACK), CEL-SCI Corporation (NYSEMKT:CVM), IGI Laboratories (NYSEMKT:IG)

CytRx Corporation (NASDAQ:CYTR) on Mar. 5 reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -4.14% in last session and finished the day at $5.10. Traded volume was 3,687,994 million shares in the last session and the average volume of the … Continue reading Biotech Most Volatile: CytRx Corporation (NASDAQ:CYTR), Merrimack Pharmaceuticals (NASDAQ:MACK), CEL-SCI Corporation (NYSEMKT:CVM), IGI Laboratories (NYSEMKT:IG)

Mark DeFrance
BioTech

Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)

German health regulators have granted Northwest Biotherapeutics Inc (NASDAQ:NWBO) special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small US biotechnology company has not yet completed its late-stage trial of the immunotherapy. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 29.55% in last session and finished the day at $7.85. Traded volume was 6,155,092 million shares in the last … Continue reading Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)

Richard Atkins